BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25529099)

  • 21. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
    Lisman T; Kamphuisen PW; Northup PG; Porte RJ
    J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal vein thrombosis.
    Parikh S; Shah R; Kapoor P
    Am J Med; 2010 Feb; 123(2):111-9. PubMed ID: 20103016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation.
    Saner FH; Gieseler RK; Akız H; Canbay A; Görlinger K
    Digestion; 2013; 88(3):135-44. PubMed ID: 24008288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portal vein thrombosis, cirrhosis, and liver transplantation.
    Francoz C; Valla D; Durand F
    J Hepatol; 2012 Jul; 57(1):203-12. PubMed ID: 22446690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding time in patients with hepatic cirrhosis.
    Blake JC; Sprengers D; Grech P; McCormick PA; McIntyre N; Burroughs AK
    BMJ; 1990 Jul; 301(6742):12-5. PubMed ID: 2383699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.
    Violi F; Ferro D
    Semin Thromb Hemost; 2013 Jun; 39(4):426-33. PubMed ID: 23487343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cirrhotic coagulopathy: A rebalanced hemostasis.
    Singh AD; Mucha SR; Lindenmeyer CC
    Cleve Clin J Med; 2022 Sep; 89(9):523-533. PubMed ID: 37907441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
    Violi F; Basili S; Raparelli V; Chowdary P; Gatt A; Burroughs AK
    J Hepatol; 2011 Dec; 55(6):1415-27. PubMed ID: 21718668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgery in Patients with Portal Hypertension.
    Wong M; Busuttil RW
    Clin Liver Dis; 2019 Nov; 23(4):755-780. PubMed ID: 31563221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ABNORMALITIES OF HEMOSTASIS IN PATIENTS WITH LIVER CIRRHOSIS].
    Majerović M; Boban A; Premužić M; Radić D; Knežević-Štromar I; Ladić A; Krznarić Ž; Rustemović N; Ostojić R
    Lijec Vjesn; 2016; 138(9-10):272-81. PubMed ID: 30148556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic liver disease and thrombosis risk].
    Aberg F; Lassila R; Ilmakunnas M; Jokelainen K; Numminen K; Mäkisalo H
    Duodecim; 2015; 131(4):321-30. PubMed ID: 26237922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group.
    Violi F; Leo R; Vezza E; Basili S; Cordova C; Balsano F
    J Hepatol; 1994 Apr; 20(4):531-6. PubMed ID: 8051393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.
    Tripodi A; Primignani M; Chantarangkul V; Lemma L; Jovani M; Rebulla P; Mannucci PM
    Liver Int; 2013 Mar; 33(3):362-7. PubMed ID: 23231699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Coagulation and Anticoagulation in Liver Transplantation Candidates.
    Northup P; Reutemann B
    Liver Transpl; 2018 Aug; 24(8):1119-1132. PubMed ID: 30142249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.
    Tripodi A; Salerno F; Chantarangkul V; Clerici M; Cazzaniga M; Primignani M; Mannuccio Mannucci P
    Hepatology; 2005 Mar; 41(3):553-8. PubMed ID: 15726661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation disorders in liver disease.
    Amitrano L; Guardascione MA; Brancaccio V; Balzano A
    Semin Liver Dis; 2002 Feb; 22(1):83-96. PubMed ID: 11928081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleeding and thrombosis in cirrhotic patients: what really matters?
    Ferro D; Angelico F; Caldwell SH; Violi F
    Dig Liver Dis; 2012 Apr; 44(4):275-9. PubMed ID: 22119620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.